Object Details
maker
Schering Corporation
Description (Brief)
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
Location
Currently not on view
Credit Line
Gift of Schering Corporation, through Steven Schneider, Vice-President
date made
1988
product expiration date
1988-03
ID Number
1987.0781.01
accession number
1987.0781
catalog number
1987.0781.01
Object Name
biological
pharmaceutical
Physical Description
Interferon alfa-2b recombinant, 5 million IU per vial (overall active ingredients)
Dilutent for Intron A Bacteriostatic water for injection, 1 mL (overall active ingredients)
Measurements
overall: 8.8 cm x 6.2 cm x 3.5 cm; 3 7/16 in x 2 7/16 in x 1 3/8 in
bottle: 8 cm x 4 cm; 3 5/32 in x 1 9/16 in
overall: 3 1/2 in x 2 3/8 in x 1 1/2 in; 8.89 cm x 6.0325 cm x 3.81 cm
place made
United States: New Jersey, Kenilworth
See more items in
Medicine and Science: Medicine
Health & Medicine
The Antibody Initiative
Biotechnology and Genetics
Recombinant Pharmaceuticals
Science & Mathematics
Antibody Initiative: Monoclonal Antibodies
Data Source
National Museum of American History
Link to Original Record
Record ID
nmah_1000950